Plantaardige middelen bij overgangsklachten

De overgang (climacterium) markeert het einde van de vruchtbare levensfase van een vrouw. Ongeveer 80% van de vrouwen krijgt overgangsklachten, met name vasomotore klachten zoals opvliegers. Verschillende plantaardige middelen kunnen deze vrouwenklachten verlichten. Zilverkaars is het populairste kruid bij overgangsklachten. Maca en ashwagandha kunnen ook soelaas bieden bij overgangsklachten, evenals pycnogenol. In deze bijdrage worden enkele van deze kruiden/ fytonutriënten besproken.

Beste bezoeker, u heeft geen toegang.

Enkel (web)abonnees hebben toegang tot tijdschriftartikelen. Het webabonnement is nog in de maak.

U kunt zich wel alvast (gratis) registreren en tal van andere webartikelen raadplegen!

Auteur

Redactie Stichting Orthokennis

Trefwoorden:

Verschenen in

Referenties

  1. Bouma J et al. NHG-Standaard De overgang (eerste herziening). Huisarts Wet. 2012;55(4):168-72.
  2. Hamerlynck JV. De medicalisering van de postmenopauze. Ned Tijdschr Geneeskd. 1988;132:1518-23.
  3. National Institute for Health and Care Excellence. Menopause. Quality Standard [QS143], 2017. https://www.nice.org.uk/ guidance/qs143
  4. Shanafelt TD et al. Pathophysiology and treatment of hot flashes. Mayo Clin Proc. 2002;77:1207-1218.
  5. Depypere HT et al. Herbal preparations for the menopause: beyond isoflavones and black cohosh. Maturitas. 2014;77:191-194.
  6. Dietz BM et al. Botanicals and their bioactive phytochemicals for women’s health. Pharmacol Rev. 2016;68(4):1026-1073.
  7. Smith TL et al. Herbal dietary supplement sales in US increase 6.8% in 2014. HerbalGram. 2015;107:52-59.
  8. Borrelli F et al. Alternative and complementary therapies for the menopause. Maturitas. 2010;66:333-343.
  9. Moore T et al. Review of efficacy of complementary and alternative medicine treatments for menopausal symptoms. J Midwifery Womens Health. 2017;00:1-12.
  10. Hajirahimkhan A et al. Botanical modulation of menopausal symptoms: mechanisms of action? Planta Med. 2013;79(7):538-53.
  11. Wuttke W et al. The non-estrogenic alternative for the treatment of climacteric complaints: black cohosh (Cimicifuga or Actaea racemosa). J Steroid Biochem Mol Biol. 2014;139:302-310.
  12. Borrelli F et al. Pharmacological effects of Cimicifuga racemosa. Life Sci. 2003;73(10):1215-1229.
  13. Rhyu MR et al. Black Cohosh (Actaea racemosa, Cimicifuga racemosa) behaves as a mixed competitive ligand and partial agonist at the human mu opiate receptor. J Agric Food Chem. 2006;54(26):9852-9857.
  14. Borrelli F et al. Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy. Pharmacol Res. 2008;58:8-14.
  15. Burdette JE et al. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem. 2003;51:5661–5670.
  16. Kockler DR et al. Antidepressants as a treatment for hot flashes in women. Am J Health Syst Pharm. 2004;61(3): 287-92.
  17. Słopień R et al. Relationship between climacteric symptoms and serum serotonin levels in postmenopausal women. Climacteric. 2003;6(1):53-7.
  18. Schellenberg R et al. Dose-dependent effects of the Cimicifuga racemosa extract Ze 450 in the treatment of climacteric complaints: a randomized, placebo-controlled study. Evid Based Complement Alternat Med. 2012;2012:260-301.
  19. Drewe J et al. The effect of a Cimicifuga racemosa extracts Ze 450 in the treatment of climacteric complaints - an observational study. Phytomedicine. 2013;20(8-9):659- 666.
  20. Drewe J et al. A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients. SpringerPlus. 2015;4:65.
  21. Wuttke W et al. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas. 2003;44 Suppl 1:S67- 77.
  22. Czuczwar P et al. The safety and tolerance of phytotherapies in menopausal medicine - a review of the literature. Prz Menopauzalny. 2017;16(1):8-11.
  23. Soliman NF. Treatment of vasomotor symptoms: is there an alternative to hormone replacement therapy? Rev Gynaecol Pract 2005;5:109-14.
  24. Rostock M et al. Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints - a prospective observational study. Gynecol Endocrinol. 2011;27(10):844-848.
  25. Meissner HO et al. Use of gelatinized maca (lepidium peruvianum) in early postmenopausal women. Int J Biomed Sci. 2005;1(1):33-45.
  26. Meissner HO et al. Hormone-balancing effect of pre-gelatinized organic maca (Lepidium peruvianum Chacon): (I) Biochemical and pharmacodynamic study on maca using clinical laboratory model on ovariectomized rats. Int J Biomed Sci. 2006;2(3):260-72.
  27. Hudson T. Maca: new insights on an ancient plant. Integrative Med. 2009;7(6):54- 57.
  28. Gonzales GF. Ethnobiology and ethnopharmacology of Lepidium meyenii (maca), a plant from the Peruvian highlands. Evid Based Complement Alternat Med. 2012;2012:193496.
  29. Meissner HO et al. Hormone-balancing effect of pre-gelatinized organic maca (Lepidium peruvianum Chacon): (II) Physiological and symptomatic responses of earlypostmenopausal women to standardized doses of maca in double blind, randomized, placebo-controlled, multi-centre clinical study. Int J Biomed Sci. 2006;2(4):360-374.
  30. Stone M et al. A pilot investigation into the effect of maca supplementation on physical activity and sexual desire in sportsmen. J Ethnopharmacol. 2009;126(3):574-6.
  31. Lee MS et al. Maca (Lepidium meyenii) for treatment of menopausal symptoms: a systematic review. Maturitas 2011;70:227- 33.
  32. Brooks NA et al. Beneficial effects of Lepidium meyenii (maca) on psychological symptoms and measures of sexual dysfunction in postmenopausal women are not related to estrogen or androgen content. Menopause. 2008;15(6):1157-62.
  33. Meissner HO et al. Therapeutic effects of pre-gelatinized maca (Lepidium peruvianum Chacon) used as a non-hormonal alternative to HRT in perimenopausal women - clinical pilot study. Int J Biomed Sci. 2006;2(2):143-59.
  34. Stojanovska L et al. Maca reduces blood pressure and depression, in a pilot study in postmenopausal women. Climacteric. 2015;18(1):69-78.
  35. Meissner HO et al. Short and long-term physiological responses of male and female rats to two dietary levels of pre-gelatinized Maca (Lepidium peruvianum Chacon). Int J Biomed Sci. 2006;2(1):15-29.
  36. Meissner HO et al. Hormone-balancing and pharmacological effects of therapeutic doses of Lepidium peruvianum (maca-GO) in postmenopausal women. Menopause. 2005;12(6):813.
  37. Meissner HO et al. Hormone-balancing effect of pre-gelatinized organic maca (Lepidium peruvianum Chacon): (III) Clinical responses of early-postmenopausal women to maca in double blind, randomized, placebo-controlled, crossover configuration, outpatient study. Int J Biomed Sci. 2006;2(4):375-94.
  38. Mazaro-Costa R et al. Medicinal plants as alternative treatments for female sexual dysfunction: utopian vision or possible treatment in climacteric women? J Sex Med. 2010;7(11):3695-714.
  39. Valerio Jr LG et al. Toxicological aspects of the south american herbs cat’s claw (Uncaria tomentosa) and maca (Lepidium meyenii): a critical synopsis. Toxicol Rev 2005;24:11-35.
  40. Kohama T et al. Effect of low-dose French maritime pine bark extract on climacteric syndrome in 170 perimenopausal women. J Reprod Med. 2013;58:39-46. 41. D’Andrea G. Pycnogenol: A blend of procyanidins with multifaceted therapeutic applications? Fitoterapia 2010;81:724-736.
  41. Kohama T et al. Fitoterapia 2010;81:724-736.
  42. Maimoona A et al. A review on biological, nutraceutical and clinical aspects of French maritime pine bark extract. J Ethnopharmacol. 2011;133:261-277.
  43. Yang HM et al. A randomized, doubleblind, placebo-controlled trial on the effect of pycnogenol on the climacteric syndrome in peri-menopausal women. Acta Obstet Gynecol Scand. 2007;86:978-85.
  44. Errichi S et al. Supplementation with pycnogenol improves signs and symptoms of menopausal transition. Panminerva Med. 2011;53:65-70.
  45. Luzzi R et al. Normalization of cardiovascular risk factors in peri-menopausal women with pycnogenol. Minerva Ginecol. 2017;69(1):29-34.

Gerelateerde artikelen

Teunisbloemolie vermindert trombose-risico bij postmenopauzale vrouwen
Teunisbloemolie vermindert trombose-risico bij postmenopauzale vrouwen
Shatavari tegen overgangsklachten
Hormoon Wellness
Voeding, menopauze en de huid
Plantaardige middelen bij overgangsklachten